AlloVir, formerly ViraCyte, was founded in 2013 and is the leader in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.
Sutro Biopharma
3 followers
Active Motif
3 followers
Dyno Therapeutics
4 followers
Janux Therapeutics
1 follower
Eikon Therapeutics
3 followers
Gilead Sciences
170 followers
Regeneron
143 followers
Illumina
81 followers
Agilent Technologies
89 followers
Verily Life Sciences
48 followers
Alexion Pharmaceuticals
49 followers
Explore companies